[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360848-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360848-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","economic-and-epidemiological-burden-of-hpv-related-diseases-in-the-czech-republic-a-claims-database-analysis","Economic and epidemiological burden of HPV-related diseases in the Czech Republic - A claims database analysis","","The study examines the economic and epidemiological burden of human papillomavirus (HPV) on both men and women in the Czech Republic. Administrative healthcare claims data were used to identify HPV-related diseases via ICD-10 codes, then quantify HPV-attributable proportions and associated healthcare costs. Years of life lost (YLL) and indirect costs from premature mortality were estimated using gender-specific life expectancy and the human capital approach. Results show 100,000+ incident cases (2018–2020), mainly in females, with over 1 billion CZK medical costs and 3.29+ billion CZK indirect productivity losses.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/economic-and-epidemiological-burden-of-hpv-related-diseases-in-the-czech-republic-a-claims-database-analysis/360848/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/economic-and-epidemiological-burden-of-hpv-related-diseases-in-the-czech-republic-a-claims-database-analysis/360848.png","ImageObject",300,407,{"name":42,"@type":43},"Well Done","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How did the study identify HPV-related diseases in the Czech Republic?","Question",{"text":63,"@type":64},"It used administrative healthcare claims data and applied ICD-10 codes to identify HPV-related diseases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which populations and outcomes were assessed for burden?",{"text":68,"@type":64},"The study assessed both men and women, estimating healthcare costs and epidemiological burden, including years of life lost and indirect costs from premature mortality.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings on incident cases and costs from 2018 to 2020?",{"text":72,"@type":64},"There were over 100,000 incident HPV-related disease cases, mainly among females, with total medical costs exceeding 1 billion CZK and indirect costs over 3.29 billion CZK from productivity losses due to premature death.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360848,1790323825,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","RESEARCH ARTICLE     \nEconomic and epidemiological burden of HPV-related diseases in the Czech Republic: A claims database analysis  \nVojtěch Kamenskýa, Jana Alahakoonb, Jakub Zadákb, Karla Mothejlováa, Gleb Donina, Juliana Grand Müllerováa, Martin Rožáneka, Aleš Tichopáda, and Ivana Šarkanováa  \naDepartment of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Prague, Czech Republic; bMSD Czech Republic, Prague, Czech Republic  \nABSTRACT  \nThe study aimed to examine the economic and epidemiological burden of human papillomavirus (HPV) on both men and women in the Czech Republic. It extended beyond the typically studied cervical cancer to encompass a rising incidence of noncervical HPV-related cancers. The utilization of administrative healthcare claims data enabled the identification of HPV-related diseases using ICD-10 codes. For each identified disease, the proportion corresponding to disease cases directly attributable to HPV was analyzed in terms of the associated healthcare costs. Furthermore, the years of life lost (YLL) and indirect costs associated with premature mortality were calculated using gender-specific life expectancies and average salaries, employing the human capital approach. The findings indicate that there were over 100,000 incident cases of HPVrelated diseases between 2018 and 2020, with the majority of these occurring in females (84.2%), and the average age of the patient was 40.6 y. The total medical costs incurred by HPV-related diseases exceeded 1 billion CZK (€41.1 million) over the study period (2018–2020), with an estimated 27,436 y lost due to premature mortality. The indirect costs, attributable exclusively to productivity losses from premature mortality, amounted to over 3.29 billion CZK (€127.7 million) . These results highlight the substantial financial and health burdens HPV imposes on the Czech healthcare system, underscoring the necessity for informed policy-making and cost-effective HPV interventions, including enhanced vaccination and preventive programs.  \nARTICLE HISTORY  \nReceived 13 March 2026 Revised 8 June 2026 Accepted 24 June 2026  \nKEYWORDS  \nHuman papillomavirus; HPVrelated diseases; burden of disease; claims data  \nIntroduction  \nHuman papillomavirus (HPV) is a group of more than 200 related viruses, some of which have been associated with the onset of diverse medical conditions. HPV is prevalent worldwide and linked to a broad spectrum of clinical conditions, ranging from benign lesions to invasive cancers. Although many HPV infections are asymptomatic and transient, persistent infections caused by high-risk genotypes, most notably HPV-16 and HPV-18, but also types such as HPV-31, −33, −45, −52, and −58 are known to cause a range of precancerous lesions and cancers. 1,2 Low-risk HPV types, such as HPV-6 and HPV-11, are primarily associated with benign conditions like genital warts and recurrent respiratory papillomatosis. However, emerging evidence suggests that even low-risk types may contribute to carcinogenesis under certain conditions.3  \nHPV is most widely known for its role in the development of pre-malignant cervical lesions and cervical cancer, which remains one of the leading causes of cancer morbidity and mortality among women, particularly in low-and middle-income countries.2 However, the oncogenic potential of HPV is not limited to cervical cancer. There is an increasing body of evidence linking high-risk HPV genotypes with a wide range of cancers in both men and women, including cervical, anal, vulvar, vaginal, and penile cancers, as well as several head and neck cancers – most notably oropharyngeal cancers, but also cancers ofthe tonsil, base of the tongue, and hypopharynx.4 Of these, oropharyngeal cancer, which affects the base of the tongue and tonsils, is of particular concern given the rising incidence observed in numerous countries, particularly  \nCONTACT Ivana Šarkanová  [ivana.sarkanova@ceeor.com](ivana.sarkano","cbCaihgOWlQbJ3LZ","https://ap.wps.com/l/cbCaihgOWlQbJ3LZ","pdf",921104,12,"English","# Introduction\n## Background on HPV and disease spectrum\n## HPV-related cancers beyond cervical cancer\n## Broader impacts: genital warts and other outcomes","[{\"question\":\"How did the study identify HPV-related diseases in the Czech Republic?\",\"answer\":\"It used administrative healthcare claims data and applied ICD-10 codes to identify HPV-related diseases.\"},{\"question\":\"Which populations and outcomes were assessed for burden?\",\"answer\":\"The study assessed both men and women, estimating healthcare costs and epidemiological burden, including years of life lost and indirect costs from premature mortality.\"},{\"question\":\"What were the key findings on incident cases and costs from 2018 to 2020?\",\"answer\":\"There were over 100,000 incident HPV-related disease cases, mainly among females, with total medical costs exceeding 1 billion CZK and indirect costs over 3.29 billion CZK from productivity losses due to premature death.\"}]","Economic and epidemiological burden of HPV-related diseases in the Czech Republic - A claims database analysis | PDF",1790141802,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d386db9258f9f53ee107d593cf097d11.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70c14ee5a979440c0fe092871ff1988e.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64bb501ee9d39df1e10e192af480efe5.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d390bd581d34e5359b1bf7f092bb0dfc.webp",980,1306]